Exciting news for investors and interested parties as JTC Team, a leading corporate communications and investor relations firm, has announced the final line-up of companies participating in the upcoming Virtual Investor Pitch Conference. The conference, set to take place on June 17 – 18, 2024, promises two days of live video webcast presentations and Q&A sessions starting at 9:00 AM ET.
Participating companies will have the opportunity to present their ‘elevator pitch’ and discuss upcoming milestones. Attendees can also engage with the companies by submitting questions during the live event, with the companies addressing as many queries as possible within the allotted time.
The schedule for the event is as follows:
- Monday, June 17: Kaida BioPharma, Inc., Adolore BioTherapeutics, Inc., Palisade Bio, Inc., AIM ImmunoTech Inc., and enVVeno Medical Corporation
- Tuesday, June 18: Royalty Management Holding Corporation, GRI Bio, Inc., Outlook Therapeutics, Inc., American Resources Corporation, Annovis Bio Inc., and Moleculin Biotech, Inc.
All interested parties can access the event schedule and individual company webcast details on the official website. Webcast replays will also be available for 90 days after the live event concludes.
For more information and to participate in the Virtual Investor events, visit the official website of the conference. Don’t miss this opportunity to engage with these exciting companies and learn about their future plans and developments.
Stay tuned for more updates and insights from the Virtual Investor Pitch Conference hosted by JTC Team.
